In Brief: Xillix/Olympus
This article was originally published in The Gray Sheet
Executive SummaryXillix/Olympus: Sign letter of intent agreement under which Olympus would obtain worldwide distribution and marketing rights for Xillix' Life-Lung, Xillix says June 24. The deal expands an August 1994 agreement between the firms that appointed Olympus as distributor for the Life-Lung in Japan. FDA's Ear, Nose and Throat Panel recommended approval of the Life-Lung premarket approval application June 11 ("The Gray Sheet" June 17, p. 12). On June 27, Xillix announced receipt of regulatory approval to market the Life-Lung in France...
You may also be interested in...
While disappointing result will probably put an end to single-drug development plans in ovarian cancer, the blockbuster anti-PD-1 immunotherapy remains in combination development for the indication.
According to the plaintiff, Unilever’s Pond’s Rejuveness Anti-Wrinkle Cream is defective insofar as tested product has been found to contain unlabeled mercury, constituting negligence that has resulted in user injuries. The plaintiff seeks certification of a transnational class and compensatory and punitive damages, among other relief.
HBW Product Launches: New Chapter Collagen, Alkamind Acid-Kicking, GNC China, Tetra Bio Canada, More
GNC, Harbin launch supplements in China following regulatory approval; Bee Gone expands with allergy swabs; Bed, Bath & Beyond expands distribution of CBDMedic personal care products promoted by Rob Gronkowski; Tetra Bio has Canadian OK For hemorrhoid and pain relief OTCs, US and European pending; Agrozen offers Urban Daze CBD products; New Chapter portfolio expansion also includes fermented vitamins, elderberry supplements and magnesium; and Alkamind’s Acid-Kicking Coffee Alkalizer creamers help neutralize acid from coffee.